ZBH

ZIMMER BIOMET HOLDINGS, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842CIK 1136869Held by 13 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$8.23B

Net Income FY2025

$0.71B

EPS (Basic, as reported)

$3.56

Net Margin FY2025

8.6%

ROE FY2025

5.6%

Total Equity

$12.70B

Shares Out

191M

Business description

ZIMMER BIOMET HOLDINGS, INC. — Orthopedic, Prosthetic & Surgical Appliances & Supplies. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 7,668 → 8,232 +0.8% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue7,6687,8037,9337,9827,0257,8366,9407,3947,6798,232

Cost of revenue(2,382)(2,133)(2,272)(2,253)(2,128)(2,341)(2,019)(2,084)(2,191)(2,494)

Gross profit——————————

Research & development——————————

Selling, general & administrative(2,933)(2,974)(3,379)(3,344)(3,178)(3,324)(2,762)(2,839)(2,930)(3,257)

Total operating expenses(6,858)(7,016)(7,899)(6,845)(7,112)(7,056)(6,244)(6,116)(6,393)(7,133)

Operating income826808341,138(88)7806961,2781,2861,098

Interest expense(358)(327)————————

Interest & investment income32————————

Other income (expense), net(71)(18)(16)(5)2512(128)(9)(31)26

Pre-tax income400465(271)906(274)4184041,0671,037831

Income tax expense(95)(1,349)(108)(226)(137)(16)(112)(42)(131)(126)

Net income3061,814(379)1,132(139)4022311,024904705

EPS — basic$1.53$8.98($1.86)$5.52($0.67)$1.93$1.10$4.91$4.45$3.56

EPS — diluted$1.51$8.90($1.86)$5.47($0.67)$1.91$1.10$4.88$4.43$3.55

Shares outstanding — basic (M)200202204205207209210209203198

Shares outstanding — diluted (M)202204204207207210210210204199

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.